Paul Daugherty: Hero is an overused term, but not in the case of Lauren Hill

 Paul Daugherty original article: Cincinnati Enquirer View Comments “Hero’’ is an overripe word in sports. Loose use has trampled its meaning, its precision, its special-ness. “The hero of the game’’ is an oxymoron. Lauren Hill was not a basketball-playing hero. She was a hero who happened to play basketball. The difference…

Continue reading

Pallone & Eshoo Applaud House Passage of Bill to Authorize President Biden’s Groundbreaking ARPA-H Initiative

FOR IMMEDIATE RELEASE June 22, 2022 CONTACT  CJ Young (202) 225-5735 Pallone & Eshoo Applaud House Passage of Bill to Authorize President Biden’s Groundbreaking ARPA-H Initiative Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) released the following joint…

Continue reading

BXQ-350 Neuroprotective Outcomes in Chemotherapy Induced Peripheral Neuropathy (CIPN) Patients

from Bexionpharma.com During Bexion’s Phase 1 study of BXQ-350 in adult patients with advanced solid tumors, a patient self-reported complete resolution of long term, persistent Chemotherapy Induced Peripheral Neuropathy (CIPN).  Due to this unexpected reporting, Bexion elected to explore this finding further by reviewing data from a cohort of patients…

Continue reading

Bexion Pharmaceuticals, Inc. to Present at the 2022 International Symposium on Pediatric Neuro-Oncology (IPSNO) Annual Conference

FOR IMMEDIATE RELEASE [Covington, KY—June 13, 2022 download the pdf Bexion Pharmaceuticals, Inc., a mid-stage clinical biopharmaceutical company, announced today that two abstracts submitted for an in-person session at the IPSNO annual meeting to be held in Hamburg, Germany, June 12-15, 2022 has been chosen for poster presentation. ISPNO is the largest…

Continue reading